Qi-Gong for improving health and quality of life in people recovering from COVID-19

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effects of Qi-Gong on individuals suffering from post-acute sequelae of SARS-CoV-2 infection (PASC). Participants will practice Qi-Gong three times a week for three months, with their physiological function and quality of life being assessed throughout the study. The trial may include a comparison group receiving standard care to determine the effectiveness of Qi-Gong. Monthly physiological data will be recorded to track improvements.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* PASC
* above 20 y/o

Exclusion Criteria:

* Those who cannot cooperate
* Severe schizophrenia

Where it's running

• Renhe nursing home
  New Taipei City, Taiwan Recruiting
• Fuxi nursing home
  Taipei, Taiwan Recruiting

Study contacts

• Principal investigator: Mei-Hua Wang — National Taipei University of Nursing and Health Sciences
• Study coordinator: Po-Chi Wu
• Email: mei.lin.w27@gmail.com
• Phone: +886900622739

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• What in the brain causes fatigue after COVID-19

  This project will see what's happening in the brains of adults with long COVID who have ongoing fatigue or brain fog to find targets for treatment.

  Recruiting Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Baltimore, Maryland · NCT07278388

• Magnetic brain stimulation for fatigue and brain fog in long COVID

  This trial will see if repetitive transcranial magnetic stimulation (rTMS) can reduce severe fatigue and improve concentration in adults with long COVID.

  Recruiting Amsterdam UMC, location VUmc · Amsterdam · NCT07278206

• Whole-body [18F]F-AraG PET/CT to map immune activity in Long COVID

  This research will try a total-body [18F]F-AraG PET/CT scan plus blood tests to see if they can detect ongoing immune activity in adults with Long COVID compared with recovered controls.

  Recruiting at 2 sites Early Phase 1 University of California, Davis · Sacramento, California and 1 other locations · NCT07076862

• Magnetic resonance and rapid brain stimulation for Long COVID cognitive and mood symptoms

  This trial will test whether an accelerated outpatient magnetic brain stimulation (iTBS) can help reduce brain fog, depression, and anxiety in adults with Long COVID.

  Recruiting Phase 2 University of New Mexico · Albuquerque, New Mexico · NCT06940609

• Evaluating remnants of SARS-CoV-2 in people recovering from COVID-19

  This study is trying to see if people who have recovered from COVID-19 still have leftover pieces of the virus in their bodies, especially those with ongoing neurological symptoms.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06577467

• Combination therapy for Long COVID symptoms using valacyclovir, celecoxib, and Paxlovid

  This study tests whether a three-drug combination can reduce Long COVID symptoms in adults compared with a placebo.

  Recruiting Phase 2 Icahn School of Medicine at Mount Sinai · New York, New York · NCT07597902

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.